VANCOUVER, March 19, 2020 /PRNewswire/ - CRH Medical Corporation (the "Company") (TSX: CRH) (NYSE MKT: CRHM), announces that Dr. Anthony Holler has advised the Company that he will resign as a member and Chair of the Board of Directors of the Company effective immediately in order to focus on other business matters.  

FOUNTAIN VALLEY, Calif., March 19, 2020 /PRNewswire/ -- Antech Diagnostics, part of Mars Petcare, announced today that its data upholds the conclusions of leading human and animal health organizations, which conclude there is currently no evidence that dogs or cats have been infected with the virus that causes COVID-19 in humans, SARS-CoV-2. Antech's acti

COVID-19 continues to spread across the world, especially in Europe. According to John Hopkins University's latest real-time statistics, as of 10:00 a.m. Beijing Time on March 19, the COVID-19 had sickened more than 217,000 people globally, with 136,100 cases diagnosed outside China (

NEW YORK, March 19, 2020 /PRNewswire/ -- Kidney patients are among the high-risk groups of people with chronic medical conditions who may experience more serious

LAGUNA BEACH, Calif. and TUCSON, Ariz., March 19, 2020 /PRNewswire/ -- There are over 30 million children nationwide who rely heavily on school meals for their basic nutrition every day.

BEIJING, March 19, 2020 /PRNewswire/ -- With the novel coronavirus sweeping across the planet, infecting an increasing number of people, the world faces severe challenges in preventing and controlling the pandemic.

BOZEMAN, Mont., March 19, 2020 /PRNewswire/ -- Pulsara recently announced they are offering their healthcare communication platform for free for COVID-19 management. While Pulsara

LONDON, March 19, 2020 /PRNewswire/ -- Following the NHS's recent letter 

EATONTOWN, N.J., March 19, 2020 /PRNewswire/ -- Caregility, a clinical collaboration and communications company focused on providing secure, reliable two-way audio and video communications for any device

CEDAR KNOLLS, N.J., March 19, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps build lean muscle, will announce financial results for the fourth quarter of 2019 on